Replies to post #73221 on Ocata Therapeutics Inc fka OCAT

[chuckanutman]

With ACTCD's Tufts dog trial reports, it would not surprise me if we bounced up to fill in the gap at $11.14 kept going past $12.04 and never looked back. Maybe wishfull thinking maybe truth. Hope the best for everyone. People have had plenty of time to cover IMO new investors, please do your own DD.